NC
EVH icon

nVerses Capital’s Evolent Health EVH Stock Holding History

nVerses Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,176
Closed -$109K – 399
2025
Q4 		$109K Buy
+27,176
New +$151K 0.24% 162
2024
Q3 		– Sell
-500
Closed -$9.56K – 1119
2024
Q2 		$9.56K Sell
500
-600
-55% -$15.3K 0.01% 903
2024
Q1 		$36.1K Buy
+1,100
New +$35.1K 0.09% 324

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

nVerses Capital's EVH Position: Q1 2026 in Review

nVerses Capital sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 27,176 shares — an estimated $109K sold.

nVerses Capital first reported a position in EVH in Q1 2024 and held it in 3 quarters. The position peaked at $109K in Q4 2025. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • nVerses Capital reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • nVerses Capital sold 27,176 Evolent Health shares in Q1 2026, an estimated $109K.
  • nVerses Capital first reported a position in Evolent Health in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Evolent Health position peaked at $109K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.